WuXi Biologics
Offering End-to-End Solutions
WuXi Biologics offers a full spectrum of discovery services and technologies for the generation, characterization, engineering, optimization and selection of high-potency novel antibody therapeutics. Our discovery technology platforms include the WuXiBody® Bispecific Antibody Platform, hybridoma systems, phage display and VHH immune libraries, and the OmniAb ® and Alloy Therapeutics transgenic technologies. All technology platforms are supported by our comprehensive research material generation and assay development capabilities. Select from the options below to learn more.